Get Live Data

SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Aukett Swanke Share Price
  4. Aukett Swanke Share Regulatory News
  5. Director/PDMR Shareholding

Pin to quick picksAukett Swanke Regulatory News (AUK)

Aukett Swanke Information
  • There is currently no data for AUK

Director/PDMR Shareholding

15 Jul 2015 16:03

RNS Number : 1650T
Aukett Swanke Group PLC
15 July 2015
 

Wednesday 15 July 2015

 

 

 

Director / PDMR Shareholding

Aukett Swanke Group Plc ("the Company")

 

 

 

The Company announces that Andrew Murdoch, a Director of the Company, has today sold 500,000 ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") at a price of 7.5 pence per share to Anthony Simmonds, the Chairman of the Company (the "Transaction").

 

Subsequent to the Transaction, Andrew Murdoch and Anthony Simmonds now hold 12,978,486 and 1,000,000 Ordinary Shares respectively. These represent beneficial interests of 7.86% and 0.61% of the issued share capital of the Company.

 

 

Enquiries

 

Aukett Swanke Group Plc - 020 7843 3000

Nicholas Thompson, Chief Executive Officer

Beverley Wright, Group Finance Director

 

finnCap - 020 7220 0500

Corporate Finance: Julian Blunt / James Thompson

Corporate Broking: Stephen Norcross

 

Hermes Financial PR

Trevor Phillips - 07889 153628

Chris Steele - 07979 604687

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEELFFEDFBBBF
123456
Date   Source Headline
3rd Mar 202510:30 amRNSChange of Name
14th Jan 202511:15 amRNSHolding(s) in Company
5th Dec 20241:08 pmRNSDirector and PCA Dealings
28th Nov 20247:00 amRNS-RNotice of presence at Anticipate London 2024
14th Nov 20247:00 amRNSChange of Auditor
18th Sep 20247:00 amRNSProperty disposal completion & Corporate update
20th Aug 20245:15 pmRNSHolding(s) in Company
20th Aug 20241:15 pmRNSHolding(s) in Company
6th Aug 20245:30 pmRNSHolding(s) in Company
1st Aug 202410:00 amRNSDirector Dealing
17th Jul 20247:00 amRNSHolding(s) in Company
15th Jul 20241:00 pmRNSAIM Rule 17 - Schedule 2(g) Update
5th Jul 20244:25 pmRNSProperty Disposal Update
28th Jun 20247:01 amRNSWarrant Exercise
28th Jun 20247:00 amRNSInterim Results
24th Jun 20247:00 amRNSProperty Disposal
4th Jun 202412:45 pmRNSSmart Buildings software contract win
29th May 20242:15 pmRNSIssue of Equity
9th May 20247:00 amRNSIssue of Warrants & Director/PDMR Notifications
26th Apr 20243:15 pmRNSResult of Annual General Meeting
26th Apr 20247:55 amRNSAGM Trading Statement
4th Apr 20247:00 amRNSSubscription Update & Director/PDMR Notifications
28th Mar 202411:52 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSFinal Results and Notice of AGM
27th Mar 202412:04 pmRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
21st Mar 20247:00 amRNSAcquisition, Subscription and Notice of Results
19th Feb 20247:00 amRNSArtificial Intelligence Consortium
14th Feb 202410:40 amRNSHolding(s) in Company
2nd Feb 20247:00 amRNSCommercial Update
4th Jan 20247:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSLaunch of Employee Share Purchase Plans
17th Nov 20232:32 pmRNSHolding(s) in Company
14th Nov 20239:02 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAcquisition of TR Control Solutions Limited
10th Oct 202311:15 amRNSHolding(s) in Company
5th Oct 202312:01 pmRNSProperty marketed for sale
17th Jul 20237:00 amRNSAcquisition of Anders+Kern U.K. Limited
27th Jun 20237:05 amRNSAppointment of Chief Operating Officer
27th Jun 20237:00 amRNSInterim Results
27th Apr 20231:20 pmRNSHolding(s) in Company
24th Apr 20237:00 amRNSAppointment of Non-Executive Director
21st Apr 202311:45 amRNSResult of AGM and Board Changes
5th Apr 20233:15 pmRNSPosting of Notice of AGM and Annual Report
4th Apr 20237:00 amRNSDisposal of Live Events Business
28th Mar 20237:00 amRNSResults for the year ended 30 September 2022
21st Mar 20237:00 amRNSResult of GM, Board Change, Acquisition Completion
2nd Mar 20237:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
1st Feb 20234:53 pmRNSChange of Adviser
30th Jan 20234:37 pmRNSHolding(s) in Company
123456

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SE11
Barclays.perp
LSE
0.00%
ZC41
Valley Fund.66a
LSE
0.00%
AVST
AVST.L
LSE
0.00%
WDSC
Ss Spdr Wldsmal
LSE
2.70%
WNDU
Ss Spdr Wld Ind
LSE
2.17%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
-43.75%
MPAL
Medpal AI
LSE
33.87%
NANO
Nanoco
LSE
18.64%
IMM
Immupharma
LSE
5.42%
ITM
Itm Power
LSE
8.98%